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Abstract Peptide nucleic acids (PNAs) are e¡ective antisense
reagents that bind speci¢c mRNAs preventing their translation.
However, PNAs cannot cross cell membranes, hampering deliv-
ery to cells. To overcome this problem we made PNAs mem-
brane-permeant by conjugation to the lipophilic triphenylphos-
phonium (TPP) cation through a disulphide bond. The TPP
cation led to e⁄cient PNA uptake into the cytoplasm where
the disulphide bond was reduced, releasing the antisense PNA
to block expression of its target gene. This method of directing
PNAs into cells is a signi¢cant improvement on current proce-
dures and will facilitate in vitro and pharmacological applica-
tions of PNAs.
' 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Peptide nucleic acids (PNAs) are DNA analogues where N-
(2-aminoethyl)glycine units replace the deoxyribose phosphate
backbone [1^3]. As the base spacing of PNAs is the same as
DNA they retain the sequence-speci¢c binding of nucleic acid
oligomers [2,4,5]. The neutral amide backbone increases both
the stability of PNAs and their binding a⁄nity to DNA and
RNA. Consequently PNAs are e¡ective antisense reagents
with therapeutic potential that bind to speci¢c mRNAs, pre-
venting their translation [4,6,7]. However, PNAs do not cross
phospholipid bilayers spontaneously [8,9]. Instead, delivery to
cells requires modi¢cation to the PNA to allow co-adminis-
tration with cationic lipids, or conjugation to cell-permeant
peptides [7,10^14].
To overcome these di⁄culties and develop a better proce-
dure to deliver PNAs to the cytoplasm, we chose to conjugate
the PNA to a triphenylphosphonium (TPP) cation (Fig. 1).
These lipophilic cations easily permeate phospholipid bilayers
and are accumulated into the cytosol driven by the plasma
membrane potential [15^17]. Most importantly, conjugation
to TPP drives PNA uptake into cells through the plasma
membrane [18]. However, TPP-conjugated PNAs are only
transiently present in the cytosol and rapidly redistribute to
mitochondria, driven by the mitochondrial membrane poten-
tial [18]. To use TPP to deliver a PNA to the cytosol instead
of mitochondria we attached the thiol-containing TPP deriv-
ative 4-thiobutyltriphenylphosphonium (TBTP) [19] to a PNA
by a disulphide bond (Fig. 1A). Disulphides are stable in the
oxidising extracellular environment but are rapidly reduced by
the intracellular glutathione pool. This should release the ac-
tive PNA within the cytosol while the displaced TBTP is ex-
pected to initially accumulate in mitochondria before gradu-
ally di¡using out of the cell [19] (Fig. 1B).
Here we show that disulphide conjugation of a PNA to
TBTP leads to e⁄cient PNA uptake into cells. In the cyto-
plasm the disulphide bond is rapidly reduced, releasing the
antisense PNA which then decreases the expression of its tar-
get gene. This procedure is a signi¢cant improvement on cur-
rent procedures for PNA delivery to cells, and will facilitate
both in vitro and pharmacological applications of PNAs.
2. Materials and methods
2.1. Synthesis of bis-[(4-thiobutyl)triphenylphosphonium] (bisTBTP)
Acylated TBTP was synthesised as described [19]. To generate the
free thiol, TBTP, acylated TBTP (500 mg; 1 mmol) dissolved in 0.5 ml
95% ethanol was incubated with 0.5 ml 1 M NaOH for 20 min at
room temperature under argon. The TBTP solution was then diluted
with 40 ml 150 mM HEPES, pH 7.3 and the thiol oxidant diamide
(200 mg; 1.16 mmol) was added. Diamide rapidly oxidised TBTP to
bisTBTP, as assessed by the disappearance of TBTP thiols assayed by
reaction with 5,5P-dithiobis (2-nitrobenzoic) acid to form 5-thio-2-ni-
trobenzoic acid (O412 = 13.6U103 M31 cm31) [20]. After incubation for
1 h at room temperature the reaction was quenched with 20 ml 1 M
HCl, 0.5 g NaBr was added and the aqueous solution extracted three
times with 40 ml dichloromethane. The pooled dichloromethane frac-
tions were concentrated by evaporation under reduced pressure to
V50 ml and bisTBTP was precipitated by addition of diethyl ether
(50 ml). The white powder was ¢ltered, washed with diethyl ether and
air dried (244 mg, 48% yield). The identity of bisTBTP was con¢rmed
by 1H nuclear magnetic resonance spectroscopy in CDCl3, acquired
using a Varian Gemini 200 MHz spectrometer. The analysis gave the
following peaks: d 7.6^8.0 (30 H, m, (Ph3P-CH2-CH2-CH2-CH2)2S2),
d 3.92 (4H, b, (Ph3P-CH2-CH2-CH2-CH2)2S2), d 2.80 (4H, t, J=7.2
H2 (Ph3P-CH2-CH2-CH2-CH2)2S2), d 2.06^2.11 (4H, m, (Ph3P-CH2-
CH2-CH2-CH2)2S2), d 2.09 (4H, m, (Ph3P-CH2-CH2-CH2-CH2)2S2),
d 1.74 (4H, m, (Ph3P-CH2-CH2-CH2-CH2)2S2). The identity of
bisTBTP was further con¢rmed by base hydrolysis with 1 M NaOH,
which exposed 1.90^2.0 mol sulphydryl groups per mol bisTBTP. Free
thiols were not detected in bisTBTP.
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2.2. Synthesis and puri¢cation of disulphide-conjugated TPP-PNAs
PNAs were synthesised by Applied Biosystems (Bedford, MA,
USA). Two oligomers were made with N-terminal biotin or £uores-
cein and a C-terminal cysteine incorporated by standard procedures.
These were BioPNAsh (Biotin-oo-GTTGGCTCTCT-o-Cys-CO2H)
and FluPNAsh (£uorescein-oo-TTCACACCCCCGTGCC-o-Cys-
CO2H), where the linker o is an 8-amino-3,6-dioxanoic acid residue.
To conjugate these PNAs to TBTP, PNA oligomers (50 nmol) in 50 Wl
10 mM HEPES, 1 mM EDTA, pH 7.5 were incubated with 100 nmol
of tris[2-carboxyethyl]phosphine hydrochloride at 37‡C for 1 h to
ensure complete reduction of the PNA thiol. Then bisTBTP (500
nmol) in 20 Wl 10 mM HEPES, 1 mM EDTA, pH 7.5 was added
and incubated at 37‡C for a further 4 h. The reaction products were
separated by reverse-phase high performance liquid chromatography
(HPLC) on a C4 analytical column (Vydac, 300 AR , 4.6 mmU250 mm),
using a Waters 450 HPLC system and a linear gradient from 0.1%
tri£uoroacetic acid (TFA) in water to 90% acetonitrile and 0.1% TFA,
run over 30 min. Peaks were detected by absorbance at 260 nm,
collected, lyophilised and dissolved in water for further analysis.
The concentrations of the PNAssTBTP conjugates were determined
at 55‡C using extinction coe⁄cients at 260 nm of 100 400 M31 cm31
(BioPNAssTBTP) and 161 500 M31 cm31 (FluPNAssTBTP). These
were derived by adding the extinction coe⁄cient of BioPNAsh
(97 900 M31 cm31) or FluPNAsh (159 000 M31 cm31) to that of
TBTP (2500 M31 cm31 at 260 nm [19]). Samples were analysed by
matrix assisted laser desorption/ionisation time of £ight mass spec-
trometry (MALDI-TOF MS) using a Finnigan MAT Lasermat 2000
instrument. For this PNA conjugates (V0.5 pmol) in water were
mixed with 3,5-dimethoxy-4-hydroxycinnamic acid (V0.5 Wl of a
10 mg/ml solution) and after crystallisation spectra were acquired in
positive ion mode using melittin (Mr 2846) as an external mass cali-
brant.
2.3. Cell culture and incubations
The cells used were the human osteosarcoma 143B cell line, the
murine leukaemia P388 cell line and early passage (V3^7) human
skin ¢broblasts. All cells were grown at 37‡C under a humidi¢ed at-
mosphere of 95% air/5% CO2 in Dulbecco’s modi¢ed Eagle’s medium
(DMEM) supplemented with 10% inactivated foetal calf serum (FCS),
100 U/ml penicillin and 100 Wg/ml streptomycin. For incubations in
suspension, 143B cells were harvested using trypsin and 106 cells were
suspended in 1 ml DMEM, supplemented with 10 mM HEPES, pH
7.0 and 10% FCS. For cell subfractionation, 143B cells were grown to
con£uence in 24 well tissue culture plates overnight and then incuba-
ted with 1 WM PNA conjugatesT 10 WM carbonylcyanide-p-tri£uoro-
methoxyphenylhydrazone (FCCP) for 1 h at 37‡C. After washing o¡
the medium the cells were harvested by scraping in 250 mM sucrose,
20 mM MOPS, 3 mM EDTA, pH 6.7 containing 1 mg/ml digitonin
and homogenised. A mitochondria-enriched fraction was prepared
from 200 Wl of the crude homogenate by centrifugation (10 000Ug,
1 min) through 300 Wl oil (58% silicone oil (Dow Corning)/42% dioctyl
phthalate) into 100 Wl 0.5 M sucrose/0.1% Triton X-100, leaving a
cytosol-enriched upper layer [21]. About 92^96% of the mitochondrial
marker enzyme citrate synthase and 0.3^1% of the cytosolic marker
enzyme lactate dehydrogenase were found in the mitochondria-en-
riched fraction. Protein was quantitated by the bicinchoninic acid
assay using bovine serum albumin (BSA) as a standard [22]. Cytotox-
icity was determined by two methods: measuring the release of the
cytosolic enzyme lactate dehydrogenase into the culture medium
[21], and assessing cell proliferation by the 3-[4,5-dimethylthiazol-2-
yl]-2,5-diphenyl tetrazolium bromide (MTT) assay using the Roche
Cell Proliferation kit I (MTT) according to the manufacturer’s in-
structions.
2.4. Gel electrophoresis and immunoblotting
For detection of PNA conjugates in 143B cells, cell lysates were
suspended in 20 Wl loading bu¡er (50 mM Tris, 4% sodium dodecyl
sulphate (SDS), 12% glycerol, 2% 2-mercaptoethanol, 0.01% Coomas-
sie brilliant blue) and were separated on 18.5% Tris-Tricine gels using
a Bio-Rad Mini Protean system [23]. For Pax2 protein detection, P388
cell lysates were suspended in loading bu¡er and were resolved on
12.5% SDS^polyacrylamide gel electrophoresis (PAGE) gels. Gels
were then electrotransferred onto nitrocellulose using a Bio-Rad
Mini Trans-Blot system in transfer bu¡er (25 mM Tris^HCl, pH
8.3, 192 mM glycine, 20% methanol) and then blocked with 2%
(w/v) fat-free milk powder in TBS (5 mM Tris^HCl, pH 7.4, 20
mM NaCl), 0.1% Tween 20. Rabbit anti-Pax2 polyclonal antiserum
(Zymed) was diluted 1:1000 in TBS, 0.1% fat-free milk powder, 0.1%
Tween 20. Rabbit anti-histone H3 polyclonal antiserum (Abcom) was
diluted 1:500. Horseradish peroxidase conjugated to goat anti-rabbit
IgG (1:10 000, Bio-Rad) was used as a secondary antibody. To detect
biotin, horseradish peroxidase-conjugated extravidin (1:3000, Sigma)
was used. In both cases secondary antibody binding was visualised by
chemiluminescence using a Pierce Super Signal R chemiluminescence
substrate with Kodak X-OMAT1 AR imaging ¢lm.
2.5. Fluorescence microscopy
For real-time £uorescence microscopy of live cells, human ¢bro-
blasts were grown overnight in 35 mm Petri dishes to 80% con£uence.
Following incubation for 1 h at 37‡C with 1 WM FluPNAssTBTP the
cells were incubated with 25 nM MitoTracker Red (Molecular Probes)
for 30 min. The cells were then washed in TBS (3U10 min) and fresh
DMEM added. Images were acquired using a Zeiss inverted confocal
microscope with a Plan-Neo£uar 40U/1.3 oil DIC objective, line 488
nm and Zeiss Imaging Software with equal exposure times for all
images shown. For immunocytochemistry human ¢broblasts
(V5000 cells per well) were plated overnight onto 13 mm glass cover-
slips in 24 well plates. Following incubation for 1 h at 37‡C with 1 WM
BioPNAssTBTP, cells were ¢xed with 4% paraformaldehyde in TBS
for 30 min, washed with TBS and incubated with 10% FCS/0.1%
Triton X-100/TBS (TBST) for 10 min. Cells were then incubated over-
night at 4‡C with the IgG fraction of anti-TBTP serum, diluted 1:500
in TBS. The IgG fraction of preimmune serum gave no immunoreac-
tivity (data not shown). After washing with TBS (3U5 min) the cells
were incubated for 15 min in the dark with anti-rabbit IgG conjugated
to the Oregon green £uorophore (Molecular Probes), diluted 1:100 in
TBS. To detect biotin, the cells were washed in TBS and incubated for
another 15 min with streptavidin-conjugated CY3 (1:200, Molecular
Probes) in the dark. Cells were then washed in TBS, mounted in
DABCO/PVA medium (15 g polyvinyl alcohol, 15 g 1,4-diazabicyclo
(2,2,2) octane in 30% glycerol in 0.1 M Tris, pH 8.5) and mounted on
coverslips [18]. Images were acquired using a Bio-Rad MRC 600 laser-
scanning confocal microscope using a Nikon Diaphot TMD inverted
microscope and Nikon U60 NA 1.4 oil immersion Plan-Apochromat
objective. The 568 nm and 488 nm lines of a krypton^argon laser and
K1/K2 ¢lter blocks were used at identical gain, black settings and time
frame.
2.6. Real-time polymerase chain reaction (PCR)
Total RNA was isolated from cells using the RNeasy kit (Qiagen).
First-strand cDNA was produced from 2 Wg of random hexamer-
primed total RNA using reverse transcription reactions (20 Wl) con-
taining 15 mM (NH4)2SO4, 20 mM Tris^HCl (pH 8.8), 2 mM MgCl2,
0.05% Tween 20, 500 WM dNTPs (Roche), 0.2 mM dithiothreitol, 10
WM random hexamer primer (Roche), 1 U DNase I (Roche), 1 U
RNasin (Promega), and 200 U Superscript II reverse transcriptase
(Life Technologies). Reactions were incubated at 42‡C for 50 min.
Relative quantitation by real-time PCR was carried out using
SYBR green detection of PCR products in real time using either the
ABI Prism 7700 or ABI Prism 7000 Sequence Detection System (Ap-
plied Biosystems). In each experiment, the L2-microglobulin (Lm)
housekeeping gene was ampli¢ed as a reference standard. Primers
for Lm were LmF, 5P-TGCAGAGTTAAGCATGACAGTATGG-3P
and LmR, 5P-TGATGCTTGATCACATGTCTCG-3P. In all real-
time PCR experiments cDNA and genomic DNA samples were in-
cluded as negative controls. Template RNAs were treated with DNase
I prior to ampli¢cation, according to the manufacturer’s instructions
(Applied Biosystems). Each real-time PCR reaction (25 Wl) contained
2.5 Wl of cDNA, 12.5 Wl of 2USYBR Green Master Mix (Applied
Biosystems), including Amplitaq polymerase (Perkin-Elmer), and
primers at a ¢nal concentration of 20 WM. Primers for the Pax2
gene were designed using Primer Express (Applied Biosystems). Prim-
ers were as follows: Pax2F, 5P-GTTCCCAGTGTCTCATCCAT-3P ;
Pax2R, 5P-GCTGGTTCACACCCCCG-3P. Reactions were prepared
in duplicate and heated to 95‡C for 10 min followed by 40 cycles at
95‡C for 15 s and 58‡C for 60 s, with a ¢nal incubation at 95‡C for 15
min. To detect the log phase of ampli¢cation, the £uorescence level
(quanti¢cation of product) was determined at each cycle. The cycle at
which the £uorescence reached threshold (CT) was recorded and aver-
aged between duplicates.
FEBS 27950 22-12-03 Cyaan Magenta Geel Zwart
A. Filipovska et al./FEBS Letters 556 (2004) 180^186 181
3. Results and discussion
3.1. Synthesis, puri¢cation and characterisation of
PNAssTBTP conjugates
To conjugate TBTP to a PNA we synthesised a novel di-
sulphide reagent, bisTBTP, by the oxidative dimerisation of
TBTP (Fig. 1A). A PNA incorporating a C-terminal cysteine
(PNAsh) was obtained by conventional automated PNA syn-
thesis. Incubation of excess bisTBTP with PNAsh led to the
formation of a disulphide bond between TBTP and the PNA
by spontaneous thiol^disulphide exchange (Fig. 1A). The re-
sulting PNAssTBTP was easily puri¢ed by reverse-phase
HPLC, as is shown for the biotin-tagged BioPNAssTBTP
(Fig. 2A), and its identity con¢rmed by MALDI-TOF MS
(Fig. 2B). To demonstrate that BioPNAssTBTP had a
TBTP at one end and a biotin at the other, the construct
was probed using antiserum against TBTP, and with strepta-
vidin (Fig. 2C). A PNAssTBTP containing a £uorescein tag
(FluPNAssTBTP) was synthesised and puri¢ed by the same
procedures: all the PNA derivatives synthesised are shown in
Fig. 2D. This synthetic scheme can be applied easily to any
PNA containing a thiol by incubation with bisTBTP prior to
the ¢nal HPLC puri¢cation.
3.2. PNAssTBTP conjugates are taken up rapidly by cells
The toxicity of the derivatised PNAs was expected to be
low. This is because within the cell the PNAssTBTP will be
rapidly converted to a free PNA and to TBTP. Consequently
Fig. 1. Synthesis and uptake of PNAs conjugated to TBTP by a disulphide bond. A: The synthesis of PNAssTBTP by thiol^disulphide ex-
change on incubating excess PNA with bisTBTP is shown. B: The lipophilic TBTP cation enables rapid transport of the PNAssTBTP conju-
gate across the plasma membrane. In the cytoplasm the disulphide bond is reduced by the endogenous glutathione pool, leaving the PNA free
in the cytoplasm. The TBTP cation will initially distribute to the mitochondria and from there slowly wash out of the cell.
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the toxicity of a PNAssTBTP conjugate will be a composite of
the toxicity of its two components. PNAs at concentrations up
to several hundred micromolar are non-toxic to cells in cul-
ture [2]. The toxicity of a wide range of small molecule TPP
derivatives such as TBTP has been investigated for many dif-
ferent types of cell in culture and shown to be low, below
about 5^10 WM [24^28]. Concentrations of up to 500 WM of
TPP derivatives can be administered to mice in their drinking
water without toxicity [16]. In addition, a TPP^PNA conju-
gate concentration of 10 WM was non-toxic when incubated
with human myoblasts for up to 3 weeks [18]. We con¢rmed
that BioPNAssTBTP concentrations up to 5 WM were not
cytotoxic by incubations with 143B cells for up to 4 days.
This treatment did not increase lactate dehydrogenase release
into the extracellular medium, or a¡ect the amount of MTT
accumulation, relative to control incubations. Therefore in
subsequent experiments we used a PNAssTBTP concentration
of 1 WM, con¢dent that there was no cytotoxicity.
To see if BioPNAssTBTP was accumulated into the cytosol,
we incubated it with human osteosarcoma 143B cells for 1 h
and then separated the cells into cytosol- and mitochondria-
enriched fractions. These were resolved by electrophoresis on
a Tris-Tricine gel, transferred to nitrocellulose and probed for
the biotin tag using streptavidin (Fig. 3A). This showed that
BioPNAsh was present only in the cytosol and not in the
mitochondria. Abolition of the mitochondrial membrane po-
tential with the uncoupler FCCP did not a¡ect the intracel-
lular distribution of BioPNAsh, further indicating that mem-
brane potential-dependent uptake into mitochondria was not
occurring (Fig. 3A). When FluPNAssTBTP was incubated
with cells it too was taken up into the cytosol and not into
mitochondria (Fig. 3B). There was no uptake of non-TBTP-
conjugated PNAs under these conditions (data not shown), in
agreement with the literature [8,9]. To con¢rm that the disul-
phide bond linking TBTP and the PNA was cleaved within
the cell we investigated the labelling of mitochondrial and
cytosolic thiol proteins by the TBTP released on reduction
of FluPNAssTBTP by intracellular glutathione. Cells were
incubated with FluPNAssTBTP for 1 h, separated into cyto-
sol- and mitochondria-enriched fractions and the proteins sep-
arated by non-reducing SDS^PAGE to preserve disulphide
bonds between TBTP and thiol proteins [19,24]. The proteins
were then transferred to nitrocellulose and probed with anti-
serum against TBTP (Fig. 3C). As a positive control we incu-
bated cells with the mitochondria-targeted thiol reagent 4-
iodobutyltriphenylphosphonium (IBTP) which accumulates
within mitochondria and there labels thiol proteins [25].
TBTP reacted with mitochondrial, but not cytosolic, thiol
proteins and the pattern of labelling was similar to that by
IBTP (Fig. 3C). These data indicate that the disulphide bond
Fig. 2. Puri¢cation and characterisation of BioPNAssTBTP. A: Puri¢cation of BioPNAssTBTP. After reaction of BioPNAsh with bisTBTP the
reaction product was puri¢ed by reverse-phase HPLC. The major peak at V16 min (asterisk; BioPNAssTBTP) was collected and lyophilised.
B: Characterisation of BioPNAssTBTP by MALDI-TOF. The observed Mr for BioPNAssTBTP (4090.7) was within 0.01% of the calculated
Mr (4091.8). C: Immunoblotting of BioPNAssTBTP. Serial dilutions of BioPNAssTBTP were adsorbed onto nitrocellulose and the TBTP moi-
ety detected using anti-triphenylphosphonium serum [25]. BSA conjugated to IBTP was used as a positive control [25]. Horseradish peroxidase
conjugated to extravidin was used to detect biotin and the BioPNAsh oligomer was used as a positive control. Control PNAs, lacking biotin
and TBTP, were not detected by either procedure (data not shown). D: List of PNA oligomers synthesised along with their sequences and Mr.
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Fig. 3. Uptake, intracellular distribution and antisense e⁄cacy of PNAssTBTPs. A: Uptake of BioPNAssTBTP by cells. A suspension of 143B
cells (106 cells) was incubated with 1 WM BioPNAssTBTP in the presence or absence of 10 WM FCCP for 1 h. The cells were then isolated and
separated by homogenisation with digitonin into mitochondria- and cytosol-enriched fractions. The fractions (20 Wg protein) were separated on
Tris-Tricine gels, transferred to nitrocellulose and probed with streptavidin-linked horseradish peroxidase. BioPNAsh (5 nmol) was used as a
positive control. The experiment was repeated four times with identical results. B: Uptake of FluPNAssTBTP by cells. A suspension of P388
cells (106 cells) was treated with 1 WM FluPNAssTBTP in the presence or absence of 10 WM FCCP for 1 h and the cells were then separated
into mitochondria- and cytosol-enriched fractions as described in A. The fractions (20 Wg protein) were separated on Tris-Tricine gels and the
£uorescence of the FluPNAssTBTP and FluPNAsh conjugates detected using a GelDoc £uorescence imager. The experiment was repeated three
times with identical results. C: Detection of TBTP within cells incubated with FluPNAssTBTP. P388 cells were treated with 1 WM FluPNAss-
TBTP for 1 h and were then separated into mitochondria- and cytosol-enriched fractions as in B. The fractions were then resolved by non-re-
ducing SDS^PAGE, transferred to nitrocellulose and the TBTP moiety detected using anti-triphenylphosphonium serum. D: Uptake of FluP-
NAssTBTP by cells. P388 cells were incubated for 1 h with 1 WM FluPNAssTBTP or FluPNAsh and then for 30 min with 25 nM
MitoTracker Red (Molecular Probes). Images of the live cells were then acquired (green=£uorescein; red=MitoTracker). E: BioPNAssTBTP
uptake by human ¢broblasts visualised by immunoconfocal microscopy. Cells were incubated with 1 WM BioPNAssTBTP or BioPNAsh for 1 h.
Cells were ¢xed, incubated with antiserum against TBTP (green) and a streptavidin-linked £uorophore to detect the biotin-tagged PNA (red)
and the images acquired as described in Section 2. Magni¢cation, 1400U. Scale bars, 20 Wm. F: Pax2 protein expression in cells treated with
FluPNAssTBTP. P388 cells grown in 24 well culture plates were incubated with 1 WM FluPNAssTBTP, FluPNAsh or no additions for 4 days.
At the end of the treatment cells from two wells were pooled and lysed in 50 Wl loading bu¡er, and 25 Wl aliquots (20 Wg protein) were resolved
by SDS^PAGE gels, transferred to nitrocellulose and probed with a Pax2-speci¢c antibody (upper panel), or anti-histone H3 antibody to check
for equal protein yields and for non-speci¢c e¡ects of FluPNAssTBTP on protein expression. Data are from day 4 of an incubation and were
repeated four times with identical results. Results after two or three days’ incubation were similar (data not shown). G: Levels of Pax2 mRNA
in FluPNAssTBTP-treated cells. Cells were incubated with 1 WM FluPNAssTBTP, FluPNAsh or no additions as in F. Then total RNA was ex-
tracted from cells and the level of Pax2 mRNA and that of a housekeeping gene, Lm, were determined by real-time PCR. Data are the cycle
at which £uorescence reached threshold (CT), divided by the CT for a control cell incubation after one day and are meansTS.D. for three
measurements. This experiment was repeated twice with identical results.
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linking TBTP and the PNA is rapidly broken in the reducing
environment within the cell. The TBTP released is then taken
up by mitochondria where a proportion forms disulphide
bonds with thiol proteins [19].
We next assessed the uptake of FluPNAssTBTP into cells
using laser scanning confocal £uorescence microscopy (Fig.
3D). The large ¢eld containing a number of live cells indicates
that FluPNAssTBTP (green £uorescence) was taken up into
the cytoplasm of most (s 90%) of the cells present over 1 h,
while the underivatised FluPNAsh was not (Fig. 3D). Label-
ling of mitochondria within these cells with MitoTracker Red
(red £uorescence) indicated that similar cell numbers were
present in both ¢elds and that the cells were viable (Fig.
3D). In live cells it was not possible to assess by immunohis-
tochemistry the location of the TBTP released on cleavage of
the FluPNAssTBTP. Therefore we next incubated cells with
BioPNAssTBTP or BioPNAsh for 1 h, then ¢xed the cells and
probed for both biotin and TBTP by confocal immuno£uo-
rescence microscopy (Fig. 3E). There was PNA uptake into
cells incubated with BioPNAssTBTP (red £uorescence; Fig.
3E, upper panel), but not into cells incubated with BioPNAsh
(Fig. 3E, lower panel). The distribution of thiol proteins la-
belled by TBTP (green £uorescence; Fig. 3E, upper panel)
showed punctate staining consistent with a mitochondrial lo-
calisation. These data corroborate those in Figs. 3A^C, con-
¢rm that the disulphide bond linking the PNA and TBTP is
rapidly broken within the cell and indicate that TBTP and
BioPNAsh are present in separate compartments.
Together, these experiments indicate that conjugation of a
PNA to TBTP by a disulphide bond leads to PNA accumu-
lation into the cytoplasm far more rapidly than incubating
cells with an unmodi¢ed PNA. The disulphide bond is re-
duced rapidly in the cytoplasm and the PNA is retained in
the cytoplasm or nucleus; the TBTP goes to the mitochondria
and is then expected to di¡use gradually out of the cell [16,19].
Hence the PNAssTBTP constructs behave as predicted in Fig.
1B.
3.3. PNAssTBTP conjugates are e¡ective antisense agents
The ¢nal step was to determine whether the PNA delivered
to the cytosol by disulphide conjugation to TBTP is e¡ective
as an antisense agent against a target gene. The FluPNA-
ssTBTP sequence is complementary to a unique region of
the mRNA of the mouse Pax2 gene (accession number
X55781.1), required for kidney and eye development in mice
[29]. Therefore we determined whether prolonged incubation
of mouse P388 cells, which express high levels of the Pax2
protein [30], with FluPNAssTBTP decreased expression levels
of the mouse Pax2 protein. To do this, we incubated mouse
cells with FluPNAssTBTP, FluPNAsh or no additions for
4 days and measured the levels of Pax2 protein by immuno-
blotting (Fig. 3F). There was a dramatic loss of 85^90% of the
Pax2 protein relative to controls on incubation with Flu-
PNAssTBTP, while FluPNAsh had no e¡ect (Fig. 3F). Flu-
PNAssTBTP did not decrease the level of Pax2 mRNA, as
measured by real-time PCR (Fig. 3G). This is expected as
antisense PNAs are thought to act by preventing translation
and not by a¡ecting message stability [4]. The speci¢city of
the FluPNAssTBTP for the Pax2 mRNA is indicated by the
lower panel in Fig. 3F, which shows that FluPNAssTBTP did
not a¡ect the level of expression of a control protein, histone
H3. Therefore PNAs targeted to the cytosol by disulphide
conjugation to TBTP are e¡ective and speci¢c antisense re-
agents.
3.4. Conclusions
Disulphide conjugation of TBTP to a PNA led to e⁄cient
PNA uptake into the cytosol, where the disulphide bond was
reduced and the bioactive antisense PNA was retained in the
cell. This procedure can be carried out by the conventional
automated synthesis of a PNA containing a free thiol. The
crude synthetic product is then incubated with excess bisTBTP
followed by a single reverse-phase HPLC puri¢cation to give
the ¢nal PNAssTBTP. This procedure is far more straightfor-
ward than covalently linking a cell-permeant peptide to a
PNA, or the alternative delivery strategy of ¢rst annealing
the PNA to a complementary DNA to enable it to bind to
cationic detergents [10]. Delivery facilitated by cationic deter-
gents is also strongly cell type- and PNA sequence-dependent.
As PNAs have been shown to be e¡ective antisense reagents
against many genes in a range of cells [4,6,7], and TPP-con-
jugated molecules are taken up by a wide variety of cells in
vitro and in vivo [16,17], this delivery system should be gen-
erally applicable. This approach will greatly simplify the in
vitro applications of PNAs as antisense reagents. Further-
more, as the disulphide is relatively stable in the extracellular
environment, it should be possible to use this approach to
deliver PNAs to cells in vivo, facilitating pharmacological
applications of PNAs.
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